Human Biofluids for Research
iSpecimen provides access to a broad range of blood and non-blood biofluids from both healthy patients and those with medical conditions, as well as those sourced using thousands of different analytes with corresponding test results.
From clinical remnant to banked and prospectively collected biofluids, iSpecimen streamlines procurement. We also provide access to a diverse, global network of providers to help you find the right specimen and data match for your research, including samples with hard-to-find patient profiles.
What biofluids do you need for your research? Let us know how we can help.
Finding the Right Biofluids for Your Research
The iSpecimen Marketplace® changes the paradigm, offering single-source access to millions of human biofluids and patients across a diverse network of providers—quickly and compliantly.
Disease Indications
Limitless Possibilities Where You Can Get Specific
If you need it, chances are, we can get it. Our large and growing network of partners connect their electronic medical record data directly to the iSpecimen Marketplace, allowing us to source biospecimens, including human biofluids, for research with highly specific characteristics for a broad range of disease indications. Below are some examples.
- Allergic Rhinitis
- Allergies (Seasonal)
- Ankylosing Spondylosis
- Asthma
- Autoimmune Hepatitis
- Autoimmune Liver Disease
- Goodpastures
- Graves’ Disease
- Hashimoto’s Thyroiditis
- Plaque Psoriasis
- Rheumatoid Arthritis (RA)
- Scleroderma
- Sjogrens Syndrome
- Systemic Lupus Erythematosus (SLE)
- Systemic Sclerosis
- Thrombocytopenia
- ADD
- ADHD
- Alzheimer’s Disease
- Dementia
- Epilepsy and Seizures
- Major Depressive Disorder
- Multiple Sclerosis
- Parkinson’s Disease
- Postpartum Depression
- Chagas
- Chlamydia
- COVID-19 (SARS-CoV-2)
- Ebstein Barr Syndrome (EBV/Mononucleosis)
- Gonorrhea
- Hepatitis A
- Hepatitis B
- Hepatitis C
- Herpes
- HIV / AIDS
- HTLV
- Influenza
- Invasive fungal infections
- Lyme Disease
- Syphilis
- Toxoplasmosis
- Zeka
- Abnormal Menstrual Cycle
- Cervical cancer
- Cysts
- Endometriosis
- Menopause
- Ovarian cancer
- Ovarian Disease
- Polycystic ovarian syndrome
- Polyps
- Preeclampsia
- Pregnancy
- Reproductive health
- Uterine Fibroids
Solid tumors
- Bladder Cancer
- Brain / Glioblastoma
- Breast Cancer
- Colorectal / Rectal Cancer
- Esophageal Cancer
- Head / Neck Cancer
- Kidney Cancer
- Liver Cancer
- Lung Cancer
- Melanoma
- Non-Small Cell Lung Cancer NSCLC
- Ovarian Cancer
- Pancreatic Cancer
- Prostate Cancer
- Small Cell Lung Cancer SCLC
- Uterine Cancer
Hematologic malignancies
- Acute Myeloid Leukemia AML
- B-cell Lymphoma
- Chronic Lymphocytic Leukemia CLL
- Leukemia
- Lymphoma
- Mixed lineage leukemia MLL
- Multiple Myeloma
- Myelodysplastic Syndrome MDS
- Non-Hodgkin’s Lymphoma
- Swabs, serum, plasma, blood and urine from individuals testing positive for COVID-19 and recovering patients
- COVID-19 co-morbidities
- Biospecimens of COVID-19 (SARS-CoV-2) variants
- Alagille syndrome
- Alcoholic Hepatitis
- Alpha-1 Antitrypsin deficiency
- Bile duct cancer
- Biliary atresia
- Cirrhosis
- Hemochromatosis
- Hepatitis C
- Hepatitis B
- Liver transplant remnants
- NAFLD
- Angina
- Atherosclerosis
- Atherosclerotic Cardiovascular Disease (ASCVD)
- Atherosclerotic Heart Disease
- Atrial Fibrillation/Flutter (A-fib)
- Cardiomegaly
- Cardiomyopathy
- Cardiovascular Disease
- Carotid Artery Disease
- Carotid Disease
- Congestive Heart Failure (CHF)
- Coronary Artery Disease
- Deep Vein Thrombosis (DVT)
- Dilated Cardiomyopathy
- Heart Failure
- Hemophilia
- Hypertension
- Hypolipidemia
- Idiopathic Dilated Cardiomyopathy
- Ischemia/Infarction
- Ischemic Cardiomyopathy
- Ischemic Heart Disease
- Non-ischemic Cardiomyopathy
- Vascular tissue from aortic surgery
- Celiac Disease
- Colorectal Disease
- Crohn’s Disease
- Inflammatory Bowel Disease (IBD)
- Irritable-Bowel Syndrome (IBS)
- Polyps
- Pre-colonoscopy healthy controls
- Ulcerative Colitis (UC)
- Asthma
- Chronic Bronchitis
- Chronic Sinusitis
- COPD (Chronic Obstructive Pulmonary Disease)
- Cystic Fibrosis (CF)
- Influenza
- Lung Cancer
- Pulmonary Edema
Need biofluids for liquid biopsy development?
Leave The Procurement Gymnastics to Us
Liquid biopsies are transforming diagnostics, prognostics, and disease monitoring, making earlier and safer disease detection possible. However, biospecimen procurement is often a barrier to efficient liquid biopsy development. By bridging the gap between sample providers and researchers, iSpecimen increases access to biofluids and other biospecimens needed for advancing liquid biopsies.
Fresh Blood In Four Hours
Pre-Colonoscopy Samples: Custom Collections
Recent Projects Made Possible
By partnering with iSpecimen, you gain extensive access to richly annotated human biospecimens and patient encounters. This is made possible by our growing network of partners, including hospitals, biorepositories, commercial laboratories, HIEs, and other healthcare organizations around the world.
Banked Plasma & PBMCs For Early Stage Cancer
Remnant Serum from 200 Patients
Prospective Blood Collection With Imaging
Custom and Prospective Collection Experts
When you require a custom collection, iSpecimen experts are here to help. We aid in ensuring that sample matching aligns tightly with your study requirements while also closely managing your projects, from inquiry to fulfillment.
FAQs
iSpecimen manages the entire compliance and contracting process across all partner sites, simplifying procurement for researchers. By working with our extensive network of healthcare organizations, biorepositories, and laboratories, we ensure that all biospecimen collections adhere to strict ethical and regulatory standards.
iSpecimen consolidates the process under a single contract, eliminating the need for time-consuming, paperwork-heavy, multi-vendor management. This streamlined approach ensures that you can access high-quality, compliant biospecimens quickly and efficiently, allowing you to focus on your research.
Yes, iSpecimen provides access to a wide range of biofluids from patients with specific diseases or conditions. Our extensive network allows us to source biospecimens with highly specific characteristics for a broad range of disease indications, including autoimmune diseases, cancers, cardiovascular diseases, central nervous system disorders, COVID-19, gastrointestinal diseases, infectious diseases, liver diseases, respiratory diseases, and women's health conditions. iSpecimen can also provide matched sets of various sample types, and healthy normal controls.
Biofluid samples are provided with relevant information including full product details as well as donor information such as patient demographics, diagnoses, medications, procedures, outcomes data, lab test results, pathology reports, family, and social history. The level of sample annotation is dependent upon the collection type.
iSpecimen strives to provide rapid access to all biofluid products, with availability dependent on sample and collection type. Fresh samples may need to be prospectively collected, and in many cases, we offer same-day and next-day collection and delivery. Frozen samples may be immediately available from our inventory. For fresh samples, we ensure quick processing and delivery to maintain sample integrity and viability, keeping your research projects on track.
While we do not have standard volume deals for bulk orders, we are committed to exceptional customer service. We are open to discussing and implementing pricing adjustments or discounts based on your specific needs and order size.
If inventory samples are not the right match, our providers can prospectively collect new samples according to their standard collection protocols, ensuring you receive the specific specimens needed for your research.
iSpecimen implements stringent quality control measures to ensure the viability and integrity of our blood products. All samples are collected following approved standard operating procedures to maintain high cell count and viability. Fresh frozen specimens are placed in proprietary preservation media within 30 minutes of resection to preserve their biological characteristics. This rigorous process ensures that the blood products you receive meet the highest standards for your research needs.